<DOC>
	<DOCNO>NCT02557477</DOCNO>
	<brief_summary>The primary objective ass whether supplementation Omega 3/6 fatty acid improve mainstream schoolchildren 's reading ability . The secondary objective ass whether Omega 3/6 improves cognitive function attention , memory , learning , language/communication , problem solve social ability.This 3-month randomise , double-blind , placebo-controlled study follow one-way crossover ( placebo active treatment ) additional 3 month . Mainstream schoolchildren age 9-10 year initially randomise receive three Omega 3/6 capsule twice daily identical placebo . All outcome measure assess baseline , 3 month 6 month . The primary outcome measure LOGOS test , comprehensive test battery evaluate read ability . Secondary outcome measure parent-rated Attention Deficit Hyperactivity Disorder ( ADHD ) Rating Scale-IV , 5-15 scale ( domain learn , memory , language/communication problem solve ) ; Social Communication Disorders Checklist ( evaluate social ability )</brief_summary>
	<brief_title>Omega 3/6 Fatty Acids Reading Children</brief_title>
	<detailed_description>This 3-month randomized , double-blind , placebo-controlled study ( Period 1 ) follow one-way crossover ( placebo active treatment ) additional 3 month ( Period 2 ) . Participants randomize receive three Omega 3/6 capsule twice daily ( correspond daily dose 558 mg EPA , 174 mg DHA , 60 mg gamma-linolenic acid ) identical placebo capsule ( palm oil ) . All daily dos take home supervise parent . All outcome measure assess baseline 3- 6-month follow-up visit . The participant mainstream schoolchildren 3rd school year ( age 9-10 year ) . Exclusion criterion continuous supplementation Omega-3 fatty acid period longer 1 month previous year , significant medical condition ( e.g . diabetes , epilepsy ) , intellectual disability , attention-deficit hyperactivity disorder ( ADHD ) diagnosis , psychoactive medication , substance use .</detailed_description>
	<criteria>mainstream schoolchildren 3rd school year ( age 910 year ) . continuous supplementation Omega3 fatty acid period longer 1 month previous year significant medical condition ( e.g . diabetes , epilepsy ) intellectual disability attentiondeficit hyperactivity disorder ( ADHD ) diagnosis , psychoactive medication , substance use .</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>